Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUT7 | Q11130 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 2/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1479650 | 0.77 | HTR2C (0.35) | — | |
| SCHEMBL229770 | 0.71 | HTR2A (0.33) | — | |
| SCHEMBL1845859 | 0.69 | LMNA (0.36) | FUT7 | |
| SCHEMBL8937976 | 0.69 | LMNA (0.36) | FUT7 | |
| SCHEMBL11666297 | 0.68 | LMNA (0.37) | — | |
| SCHEMBL10774318 | 0.66 | TUBB4A (0.54) | FUT7CYP3A4 | |
| SCHEMBL4559892 | 0.64 | CHRM2 (0.37) | FUT7 | |
| SCHEMBL18029773 | 0.63 | SKP2 (0.39) | MAOBALDH1A1CYP3A4 | |
| SCHEMBL27695101 | 0.63 | CHRM2 (0.44) | — | |
| SCHEMBL3290599 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120295940-A1 | COMPOSITIONS FOR TREATING MASTITIS | NOBLE ION, LLC (US) | 2012-11-22 | — | — | US | claimed |
| US-20120288488-A1 | Compositions and Methods of Use for Livestock Pen Spray | NOBLE ION, LLC (US) | 2012-11-15 | — | — | US | claimed |
| US-20100298386-A1 | COMPOSITIONS AND METHODS FOR TREATING MASTITIS | BYOCOAT ENTERPRISES, INC. (PR) | 2010-11-25 | — | — | US | claimed |
| WO-2009045456-A1 | COMPOSITIONS AND METHODS FOR TREATING MASTITIS | BYOCOAT ENTERPRISES, INC. (PR) | 2009-04-09 | — | — | WO | claimed |
| US-7399731-B2 | Electrically conductive non-aqueous wellbore fluid | M-I L.L.C. (US) | 2008-07-15 | — | — | US | claimed |
| WO-2007123846-A2 | SYNTHESIS, FUNCTIONALIZATION AND ASSEMBLY OF MONODISPERSE HIGH-COERCIVITY SILICA-CAPPED FEPT NANOMAGNETS OF TUNABLE SIZE, COMPOSITION AND THERMAL STABILITY FROM MICROEMULSIONS | RENSSELAER POLYTECHNIC INSTITUTE (US) | 2007-11-01 | — | — | WO | claimed |
| EP-1608392-A4 | PAPANICOLAU STAINING PROCESS | CYTYC CORP (US) | 2007-09-05 | — | — | EP | claimed |
| US-7186522-B2 | Using detergents to reduce artifacts during staining of biological samples; medical diagnostics and cervical cancer | CYTYC CORPORATION (US) | 2007-03-06 | — | — | US | claimed |
| US-20070003998-A1 | Papanicolau staining process | THIRD WAVE TECHNOLOGIES, INC. | 2007-01-04 | — | — | US | claimed |
| EP-1608392-A2 | PAPANICOLAU STAINING PROCESS | Cytyc Corporation (US) | 2005-12-28 | — | — | EP | claimed |
| WO-2004086945-A2 | PAPANICOLAU STAINING PROCESS | CYTYC CORPORATION (US) | 2004-10-14 | — | — | WO | claimed |
| US-20040191854-A1 | Papanicolau staining process | CYTYC CORPORATION | 2004-09-30 | — | — | US | claimed |
| US-20030171446-A1 | Surface cleaner | RECKITT BENCKISER (UK) LIMITED (GB) | 2003-09-11 | — | — | US | claimed |
| EP-1240295-A2 | SURFACE CLEANER | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2002-09-18 | — | — | EP | claimed |
| WO-2001046368-A2 | SURFACE CLEANER | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2001-06-28 | — | — | WO | claimed |
| US-11779585-B2 | Method for treating coronavirus infections | OYAGEN, INC. (US) | 2023-10-10 | — | — | US | disclosed |
| US-20230285434-A1 | METHOD FOR TREATING ARENAVIRIDAE INFECTIONS | OYAGEN, INC. | 2023-09-14 | — | — | US | disclosed |
| US-20030132033-A1 | Electrically conductive non-aqueous wellbore fluid | M-I L.L.C. | 2003-07-17 | — | — | US | disclosed |
| EP-1240295-A2 | SURFACE CLEANER | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2002-09-18 | — | — | EP | disclosed |
| WO-2001046368-A2 | SURFACE CLEANER | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2001-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230285434-A1 | METHOD FOR TREATING ARENAVIRIDAE INFECTIONS | MPO, LIPA, CAT | FUT7 1462/4885MAOB 2237/4885MAOA 2856/4885 |
| US-20120288488-A1 | Compositions and Methods of Use for Livestock Pen Spray | PIGS, PLG, LCT | FUT7 629/4885MAOB 281/4885MAOA 1312/4885 |
| US-11779585-B2 | Method for treating coronavirus infections | ACE2, ACE, SARS1 | FUT7 2245/4885MAOB 921/4885MAOA 1631/4885 |
| US-20100298386-A1 | COMPOSITIONS AND METHODS FOR TREATING MASTITIS | LCT, LPO, CFB | FUT7 344/4885MAOB 222/4885MAOA 1936/4885 |
| US-20120295940-A1 | COMPOSITIONS FOR TREATING MASTITIS | LCT, LPO, MMP1 | FUT7 349/4885MAOB 404/4885MAOA 1619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.